Neurocrine Biosciences shares owned by Peregrine Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Peregrine Capital Management
from 13F filings
Historical chart of Peregrine Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Peregrine Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Peregrine Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $9.2M | 67k | 137.92 |
| 2023-12-31 | $8.9M | 67k | 131.76 |
| 2023-09-30 | $8.9M | 79k | 112.50 |
| 2023-06-30 | $8.8M | 93k | 94.30 |
| 2023-03-31 | $8.6M | 85k | 101.22 |
| 2022-12-31 | $8.1M | 68k | 119.43 |
| 2022-09-30 | $9.1M | 86k | 106.21 |
| 2022-06-30 | $8.9M | 91k | 97.48 |
| 2022-03-31 | $8.6M | 91k | 93.75 |
| 2021-12-31 | $8.3M | 98k | 85.17 |
More positions owned by Peregrine Capital Management
View all positions for Peregrine Capital Management